The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its ...

Facing challenges to access essential technical services, quality testing, research and development, besides regulatory services at competitive rates, a Contract Research Organisation (CRO)-cum ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1445 in its ...

A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...

Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...

Gilead Sciences (GILD) could open near nine-year highs after beating fourth-quarter earnings and revenue estimates ...

Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

Market research can identify ways to lower costs and improve revenues, if it is approached methodically. Here are some tips for success. The slow-down in growth in the pharma industry over the ...

For example, under a traditional pharma/biotech collaboration and licensing model, a biotech partner may have primary responsibility for significant elements of research and early product ...